1985 Lotus Esprit Turbo Low Miles Great Condition Right Color Low Reserve Look on 2040-cars
Rochester, New York, United States
Body Type:Coupe
Vehicle Title:Clear
Fuel Type:Gasoline
For Sale By:Dealer
Make: Lotus
Model: Esprit
Warranty: Vehicle does NOT have an existing warranty
Mileage: 46,696
Sub Model: Esprit Turbo
Power Options: Air Conditioning
Exterior Color: Black
Interior Color: Tan
Number of Cylinders: 4
Lotus Esprit for Sale
1977 lotus esprit base coupe 2-door(US $18,000.00)
2002 lotus esprit coupe 25th anniversary**alpine sound*glass roof**only 100 made
1993 lotus esprit turbo se coupe 2-door 2.2l
Lotus esprit 1986 turbo s3(US $15,800.00)
1995 lotus esprit s4 coupe 2-door 2.2l(US $48,000.00)
Pampered, extremely rare (1 of 62), unmolested esprit(US $22,500.00)
Auto Services in New York
Wheel Fix It Corp ★★★★★
Warner`s Auto Body ★★★★★
Vision Kia of Canandaigua ★★★★★
Vision Ford New Wholesale Parts Body Shop ★★★★★
Vince Marinaro Automotive Inc ★★★★★
Valu Muffler & Brake ★★★★★
Auto blog
Why Lotus thinks its luxury EV game plan will succeed globally
Sun, Feb 25 2024 Luxury sports car and EV maker Lotus completed its SPAC merger last week in the U.S. and its stock was publicly traded for the first time on Friday. It’s an interesting turn of events for the Geely-backed automaker now known as Lotus Tech given the uncertain EV market, but one that may prove an exception to the struggles of other pure-play EV makers. Trading under the ticker LOT on the Nasdaq, Lotus Tech will focus on the higher end of the EV market with its Eletre SUV and Emeya sedan, which will not only be offered in the US but also in Europe and, more importantly, China. “What is most important here is that we are definitely going to more markets at the same time through more models and through more stores,” said Lotus Tech CFO Alexious Lee to Yahoo Finance from the Nasdaq market site. By the end of the year Lotus will have four vehicles in production, three of them EVs. “These four models are currently available in Asia Pacific and part of it is also available in UK and EU,” Lee said. “We're having the new [Eletre] SUV model coming into the U.S. in the third quarter of this year, so different markets have different strategies and different product offerings and different conditions." Lotus is able to go to market in a number of territories due to the backing of its majority owner, Chinese auto giant Geely. But it also raised a considerable amount of money through its SPAC merger. Lotus Tech said it raised more than $880 million in pre-closing and PIPE financing commitments, with a targeted valuation on listing day of nearly $7 billion. Lotus Tech also had an interesting partner with its SPAC merging, combining with L Catterton Asia Acquisition Corp (LCAA), which is backed by French luxury conglomerate LVMH. Lotus Eletre in Solar Yellow View 11 Photos As Lotus targets the luxury segment with its vehicles — the Eletre and Emeya will be playing in the $80,000 to $150,000 ballpark — having a partner like LVMH, with its deep connections and insights into the luxury consumer, could be hugely beneficial. “Now what is more important here is Anish Melwani, who is the CEO for LVMH North America, will be on the board of Lotus Tech,” Lee said.
Volvo-based, Chinese-built Lotus SUV allegedly due out in 2020
Thu, Oct 1 2020Lotus will set foot in the lucrative SUV segment before the end of 2020, according to a recent report. It's preparing to unveil a high-riding model named Lambda that will be made in China with Swedish parts. Five-plus years in the making, the first Lotus-badged SUV will share its SPA platform with several members of the Volvo range, including the XC90, and with the plug-in hybrid Polestar 1. Citing unverified reports from China, Holland-based AutoWeek reported the Lambda will land in the same segment as the Porsche Cayenne Coupe and upmarket variants of the BMW X6. Patent images (pictured) suggest it will wear a fastback-like roof line. Using the flexible SPA platform will allow Lotus to offer a variety of powertrains, including gasoline-burning four-cylinder engines with forced induction and at least one plug-in hybrid option. SPA wasn't designed to accommodate six- or eight-cylinders, so leveraging electrification will likely be the easiest way for engineers to unlock more performance. An electric variant will reportedly join the range a little bit later in the 2020s. Production will begin in Wuhan, China, in late 2020, according to the same source. Whether the model will be sold in the United States is up in the air. It would make a significant amount of sense: Americans have an insatiable appetite for SUVs, and the company has often stressed it wants to increase its sales in our market. Lotus hasn't commented on the report, and it has remained quiet about its long-rumored SUV. We heard a lot about the model from Jean-Marc Gales, its former CEO; he notably said it will be to the Cayenne what the Evora is to the 911, and he pledged it would become the fastest and most agile model in its segment. He's gone, replaced by Phil Popham in 2018, so that strategy might have changed. If the rumor is accurate, we won't have to wait long to see how Lotus can apply its design language and its unique engineering philosophy to an SUV. Related Video:
Kimi Raikkonen to miss rest of season for back surgery
Sun, 10 Nov 2013Formula One drivers keep themselves in peak physical condition, such are the demands placed on them in order to do what they do. But otherworldly as their capabilities may be, they're still human, and that means they get injured or sick just like the rest of us.
Case in point: Kimi Raikkonen and the announcement made today by Lotus that he'll have to sit out the rest of the season in order to undergo back surgery. That means Lotus will have to find a replacement driver for the last two races in Austin and Brazil while Kimi has and recovers from the operation.
Though we wouldn't debate the legitimacy of Kimi's condition or the necessity to rectify it, the timing is sure to raise some eyebrows. Raikkonen has been at the center of a pay dispute with Lotus, and while the situation was reportedly resolved, his decision to undergo what is said to be elective surgery at this point in the season (as opposed to waiting until its end) raises some questions as to his commitment to the team he is leaving and his team's financial commitments to him in turn.